References:
[1] Chakorkar SS, Mulla JA. Cubosome-based Corticosteroids Drug Delivery System for Sustained Ocular Delivery: A Pharmacokinetic Investigation. Indian Journal of Pharmaceutical Education and Research. 2024 May 27;58(2s): s502-14.

[2] Mali JD, Mulla JA. Ocular drug delivery system: A review. World Journal of Drug Targeting. 2023;1(1):9-24.

[3] Chakorkar S, Mulla JA. Cubosomal Drug Delivery System: Promising Approach for Ocular Drug Delivery of Corticosteroids. Eur. Chem. Bull. 2023; 12:13850-81.

[4] Chakorkar SS, Mulla JA. A novel corticosteroid cubosomes–for ocular drug delivery. Indo Am J Pharm Res. 2020;10(06):322-8.

[5] S. Ahmed, M. M. Amin, and S. Sayed, Ocular Drug Delivery: a Comprehensive Review, AAPS Pharm SciTech, 2023;24:66.

[6] C. E. Willoughby, D. Ponzin, S. Ferrari, A. Lobo, K. Landau, and Y. Omidi, Anatomy and physiology of the human eye: Effects of muco polysaccharidoses disease on structure and function – a review, Clinical & Experimental Ophthalmology, 2010;38(1), pp. 2–11.

[7] Raj, Vishal Kumar, Rupa Mazumder, and Monika Madhra. Ocular Drug Delivery System: Challenges and Approaches. International Journal of Applied Pharmaceutics, 2020;12:5 49–57.

[8] Nguyen, Q. D. editors. Retinal Pharmacotherapeutics. Karger Medical and Scientific Publishe 2015;55.

[9] Guidi, Lorenzo, Maria Grazia Cascone, and Elisabetta Rosellini. Light-Responsive Polymeric Nanoparticles for Retinal Drug Delivery: Design Cues, Challenges and Future Perspectives. Heliyon, 2024;10(5).

[10] Cholkar, Kishore, Aswani Dutt Vadlapudi, Hoang M. Trinh, and Ashim K. Mitra. Compositions, Formulation, Pharmacology, Pharmacokinetic, and Toxicity of Topical, Periocular, and Intravitreal Ophthalmic Drugs. Methods in Pharmacology and Toxicology, Springer, 2013;91–118.

[11] Huang, W. C., A Novel Eye Drop Formulation for Potential Treatment of Neovascular Age-Related Macular Degeneration. Translational Vision Science & Technology, 2021;10(14) 23.

[12] Patole PJ, Mulla JA. Liposomal In Situ Gel: A Novel Approach for the Treatment of Parkinson’s Disease via Intranasal Drug Delivery. Research Journal of Pharmaceutical Dosage Forms and Technology. 2025 Mar 10;17(1):53-62.

[13] Shingate DM, Mulla JA. Exploring Liposomes: Comprehensive Classification, Preparation Techniques, and Composition Insights. Indian Journal of Novel Drug Delivery. 2024;16(2):80-90.

[14] Kumbhar AV, Thorat PA, Mulla JAS. Development and assessment of risperidone-loaded niosomal in situ gel for nasal drug delivery. Indian Drugs. 2025;62(12):41-50.

[15] Rane KA, Mulla JA. Hyaluronic Acid-Coated Niosomes: A Promising Drug Delivery System with Potential Applications. Indian Journal of Novel Drug Delivery. 2024;16(1):11-9.

[16] Mane RK, Mulla JAS. A comprehensive review on niosomes: Composition, methods of preparation, characterization and potential applications. World Journal of Nanoparticle Research. 2023;1(1):35-44.

[17] Shewale SS, Mulla JA. Non-Ionic Surfactant Vesicle (Niosome): A Novel Drug Delivery System. Indian Journal of Novel Drug Delivery. 2022;14(3):129-37.

[18] Maiti D, Inamdar MN, Almuqbil M, Suresh S, Asdaq SM, Alshehri S, Al Arfaj SA, Alamri AM, Aldohyan MM, Alqahtani MT, Alosaimi TM. Evaluation of solid-lipid nanoparticles formulation of methotrexate for anti-psoriatic activity. Saudi Pharmaceutical Journal. 2023 Jun 1;31(6):834-44.

[19] Mulla JA, Hiremath SP, Sharma NK. Repaglinide loaded solid lipid nanoparticles: design and characterization. RGUHS J Pharm Sci. 2012 Oct;2(4):41-9.

[20] Mulla JA, Khazi MI, Khan AY, Khazi IA. Design, Characterization and In vitro Evaluation of Imidazole [2, 1-b] [1, 3, 4] thiadiazole Derivative Loaded Solid Lipid Nanoparticles. Drug Invention Today. 2012 Aug 1;4(8).

[21] Mulla JS, Khazi IM, Sharma NK, Hiremath SP, Jamakandi VG. Solid lipid nanoparticles: methods of preparation. Indian J Nov Drug Deliv. 2011;3(3):170-5.

[22] Panchamukhi SI, Mulla JA, Shetty NS, Khazi MI, Khan AY, Kalashetti MB, Khazi IA. Benzothieno [3, 2‐e] [1, 2, 4] triazolo [4, 3‐c] pyrimidines: Synthesis, Characterization, Antimicrobial Activity, and Incorporation into Solid Lipid Nanoparticles. Archive der Pharmacies. 2011 Jun;344(6):358-65.

[23] Mulla JS, Khazi IM, Sharma NK. Solid lipid nanoparticles: Measures of characterization. Indian Journal of Novel Drug delivery. 2011;3(4):259-64.

[24] Mulla AS, Shetty NS, Panchmukhi SI, Khazi IA. Formulation, characterization and in vitro evaluation of novel thienopyrimidies and triazolothienopyrimidies loaded solid lipid nanoparticles. International Journal of Research in Ayurveda and Pharmacy. 2010; 1:192-200.

[25] Mulla JS, Khazi IM, Jamakandi VG. Solid lipid nanoparticles: Potential applications. Indian J Nov Drug Deliv. 2010; 2:82-7.

[26] Mulla JA, Suresh S, Khazi IA. Formulation, characterization and in vitro evaluation of methotrexate solid lipid nanoparticles. Research Journal of Pharmacy and Technology. 2009;2(4):685-9.

[27] Mulla JS, Khazi IM. Influence of process variables on particle size of solid lipid nanoparticles. Indian Journal of Novel Drug Delivery. 2009;1(1):47-9.

[28] Mujawar NK, Mulla JAS. Targeted Drug Delivery: Revolutionizing Breast Cancer Treatment with Lipid Polymer Hybrid Nanoparticles. Research Journal of Pharmacy and Technology. 2025;18(12):6129-6136.

[29] Sushant Laxman Pawar, Jameel Ahmed S Mulla. Lipomes as Hybrid Nanocarrier: Innovation in Targeted and Controlled Drug Delivery. Indian Journal of Novel Drug Delivery. 2025;17(3):150-164.

[30] Mujawar N, Mulla JAS. Lipid Hybrid Nanoparticles in Cancer Therapy: A Promising Nanotechnology-Based Drug Delivery System. International Journal of Pharmaceutical Sciences and Drug Research. 2025;17(4):371-387.

[31] Priyanka Jadhav, Jameel Ahmed S Mulla. Unlocking Nano sponges Potential: An Overview of Formulation Strategies, Assessment Approaches and Emerging applications. Indian Journal of Novel Drug Delivery. 2024;16(3):130-136.

[32] Mulla JA. Nano-based drug delivery systems: A comprehensive review of design, mechanisms and applications. World J Pharm. 2024;1(1):1-1.

[33] Mulla JA. Molecular pharmacology of nanocarrier based drug delivery systems: Mechanisms, targets, and therapeutic implications. World Journal of Molecular Pharmacology. 2024;1(1):16-23.

[34] Mulla JA, Kapse MV. Exploring nanomedicine in cancer: Diagnosis, treatment and its potential applications. IP Journal of Diagnostic Pathology and Oncology. 2024;9(2):86-94.

[35] Mulla JA, Chalke PM, Londhe SP, Patil MA, Nalawade SN, Sawant RR. Design and Optimization of Nano sponges of Poorly Soluble Voriconazole Using Central Composite Design. Indian Journal of Novel Drug Delivery. 2023;15(4):189-99.

[36] Shirke SN, Mulla JA. Intranasal nano emulsion for brain targeting: A review. Indian Journal of Novel Drug Delivery. 2023;15(1):1-1.

[37] Dhahir, Rasha Khalid Nano emulsions as Ophthalmic Drug Delivery Systems. Turkish Journal of Pharmaceutical Sciences Oct. 2021;18(5):652-64.

[38] Sutradhar, Kumar Bishwajit, and Md. Lutful Amin. Nano emulsions: Increasing Possibilities in Drug Delivery. European Journal of Nanomedicine, 2013;5(2)97-110.

[39] Mandal, Abhirup Polymeric Micelles for Ocular Drug Delivery: From Structural Frameworks to Recent Preclinical Studies. Journal of Controlled Release2017;24(8):96-116.

[40] Formica, Maria-Luiza Development and Optimization of Acetazolamide-Loaded Soluplus®-Based Polymeric Micelles for the Treatment of Glaucoma. Pharmacia, 2025;72 .

[41] Yadav, Jayanthi, Microneedles for Advanced Ocular Drug Delivery. Journal of Drug Delivery Science and Technology, Aug. 2022;74 103577.

[42] Jiang, Xiao, Hu Zhao, and Wei Li. Microneedle-Mediated Transdermal Delivery of Drug-Carrying Nanoparticles. Frontiers in Bioengineering and Biotechnology, 2022;10 840395.

[43] Rojekar, Satish Revolutionizing Eye Care: Exploring the Potential of Microneedle Drug Delivery. Pharmaceutics, 30 Oct. 2024;16(11):1398.

[44] Date RB, Mulla JAS. Nano sponges Loaded Hydrogels for Anti-Inflammatory Drug Delivery: Characterization Evaluation and Applications. Asian Journal of Pharmaceutical Research. 2026;16(1):27-32.

[45] Kadam SS, Mulla JA. Design, Development and Evaluation of Etodolac Loaded Chitosan based Nano-gel for Topical Drug Delivery. Hacettepe University Journal of the Faculty of Pharmacy. 2025;45(2):146-161.

[46] Dubald, Marion Ophthalmic Drug Delivery Systems for Antibiotherapy—A Review. Pharmaceutics 13 Jan. 2018;10(1):10.

[47] Rojekar, Satish Revolutionizing Eye Care: Exploring the Potential of Microneedle Drug Delivery. Pharmaceutics Oct. 2024;16(11):1398.

[48] Miller, L. J., and L. Cuttler. The Endocrine Effects of Inhaled Corticosteroids. Journal of Pediatric Endocrinology, 2013;26(2):65–73.

[49] Rykowska, Iwona, Iwona Nowak, and Rafał Nowak. Soft Contact Lenses as Drug Delivery Systems: A Review. Molecules, 2021;26(18):5577.

[50] Kumari, Anita Ocular Inserts—Advancement in Therapy of Eye Diseases. Journal of Advanced Pharmaceutical Technology & Research, 2010;1(3):291–296.

[51] Omer, Safaa, and Romána Zelkó. A Systematic Review of Drug-Loaded Electrospun Transferosome-based Ophthalmic Inserts. Pharmaceutics, 2021;13(10)1637.

[52] Giri, Bhupendra Raj Advancements in Ocular Therapy: A Review of Emerging Drug Delivery Approaches and Pharmaceutical Technologies. Pharmaceutics, 2024;16(10):1325.

[53] Naik KK, Ashok B, Naik N, Mulla JA, Prakasha A. DNA binding, anti-inflammatory and analgesic evaluation of metal complexes of N/S/O donor ligands; Synthesis, spectral characterization. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy. 2015 Apr 15; 141:88-93.

[54] Rathi, Aman Sohan, and Akash P. Dhoke. A Comprehensive Review of Innovations for Diabetic Retinopathy and Next-Generation Intraocular Drug Delivery. International Journal of Science and Technology 2025;1 Article 1504.

[55] Shrivastava, Nikhil, and Shikha Saxena. An Update Review on Novel Advanced Ocular Drug Delivery System. International Journal of Pharmaceutical Sciences Review and Research, 2012;15(2):64–70.

[56] Shah, S., and R. Garg. Artificial Intelligence in Remote Patient Monitoring: Opportunities and Challenges. Remote Patient Monitoring 2024;7:29.

[57] García‐Peñalosa, Cecilia, and Jean‐François Wen. Redistribution and Occupational Choice. Comprehensive Economic Policy, 2022;60:100541.

[58] Tan, Rachel Yie Hang pH Responsive Polyurethane for the Advancement of Biomedical and Drug Delivery. Polymers, 2022;14(9):1672.

[59] Augustine, Rimesh, pH-Responsive Polypeptide-Based Smart Nano-Carriers for Theragnostic Applications. Molecules, 2019;24(16):2961.

[60] Chatterjee, Sudipta, and Patrick Chi-leung Hui. Review of Applications and Future Prospects of Stimuli-Responsive Hydrogel Based on Thermo-Responsive Bio polymers in Drug Delivery Systems. Polymers, , 2021;13(13)2086.

[61] Mohanty, D., Bakshi, V., Simharaju, N., Haque, M. A., & Sahoo, C. K. (2018). A review on in situ gel: A novel drug delivery system. International Journal of Pharmaceutical Sciences Review and Research, 50(1), 175–181.

[62] Kundu, Sourabh, Gitika Kumari, and Dadi A. Srinivasarao. Emerging Drug Delivery Strategies for Glaucoma Therapy: Focus on Nanoparticles and Stimuli-Responsive Systems. RSC Pharmaceutics, 2025;2:1050–1077.

[63] Dludla, Siphokazi B. K. Current Advances in Nano-Based and Polymeric Stimuli-Responsive Drug Delivery Targeting the Ocular Microenvironment: A Review and Envisaged Future Perspectives. Polymers 2022;14(17)3580.

[64] Hu, Quanyin, Prateek S. Katti, and Zhen Gu. Enzyme-Responsive Nanomaterials for Controlled Drug Delivery. Nanoscale, , 2014;6(21):12273–12286.

[65] Lee, Seulgi Cathepsin B-Responsive Liposomes for Controlled Anticancer Drug Delivery in Hep G2 Cells. Pharmaceutics, 2020;12(9):876.

[66] Adepu, Shivakalyani, and Seeram Ramakrishna. Controlled Drug Delivery Systems: Current Status and Future Directions. Molecules, 2021;26(19):5905.

[67] Raza, Ali, Endogenous and Exogenous Stimuli-Responsive Drug Delivery Systems for Programmed Site-Specific Release. Molecules, 2019;24(6):1117.

[68] Pereira, Luís, Frederico Castelo Ferreira, Filipa Pires, and Carla A. M. Portugal. Magnetic-Responsive Liposomal Hydrogel Membranes for Controlled Release of Small Bioactive Molecules—An Insight into the Release Kinetics. Membranes, 2023;13(7):674.

[69] Dave, Drashti. Stimuli-Responsive Drug Delivery Systems: Innovations in Personalized Medicine. 2023.

[70] Chen, Xuan, Research Progress of Bioinspired Nano structured Systems for the Treatment of Ocular Disorders. Pharmaceuticals, 2023;16(1):96.

[71] Journal of Integrative and Complementary Medicine, 2024;30(1).

[72] Zhang, L., Gu, F., and J. M. Chan. Nanoparticle-Mediated Drug Delivery and Gene Therapy. International Journal of Nanomedicine, 2015;10:1–15.

[73] Banken, Elisabeth, and Johannes Oeffner. Biomimetics for Innovative and Future-Oriented Space Applications: A Review. Frontiers in Space Technologies, , 2023;3 article 1000788.

[74] Bhusari SR, Mulla JAS. Review on natural polymers and their applications. World Journal of Green Pharmacy. 2023;1(1):1-8.

[75] Tsung, Ta-Hsin Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases. International Journal of Molecular Sciences, 2023;24(16)12976.

[76] Lynch, Courtney, Advances in Biodegradable Nano-Sized Polymer-Based Ocular Drug Delivery. Polymers, 2019;11(8):1371.

[77] Shirke SN, Mulaa JAS, Chavan PV. 3D printing in pharmaceuticals: A review. World Journal of Applied Pharmaceutics. 2023;1(1):1-6.

[78] Lin, Neil, Maryse Gagnon, and Kevin Y. Wu. The Third Dimension of Eye Care: A Comprehensive Review of 3D Printing in Ophthalmology. Hardware, 2024;2(1):1–32.

[79] Singh, V., and N. M. Patrikalakis. Bézier Curve-Based Singularity Analysis in CAD. Computer-Aided Design and Applications, 2019;16(2):243–248.

[80] Lotale HH, Mulla JAS. Personalized medicine and 3D printing: A new era in drug delivery. Journal of Pharmaceutical and Biological Sciences. 2025;13(2):98-106.

[81] Qiu, Tina Guanting, and Thomas V. Johnson. Defining the Problem in Ophthalmic Drug Development and Clinical Translation. Frontiers in Pharmacology, 2020;11:1040.

[82] Zhang, Yan, Nanoparticle-Based Drug Delivery Systems for Cancer Therapy: Advances and Challenges. International Journal of Nanomedicine, 2024;19(1):123–145.

[83] Kahn, James G., and Eric Marseille. The Evidence Base for Cost-Effectiveness of HIV Treatment and Care. PLoS Medicine, 2018;15(10) :1002529.

[84] Pignatello, Rosario, and Pietro Matricardi. Steering the Clinical Translation of Delivery Systems for Drugs and Health Products. Pharmaceutics, 2020;2(4)350.

[85] Zhang, Y., Li, X., and Wang, J. A Novel Hybrid Model for Short-Term Load Forecasting Using Improved CEEMDAN and Temporal Convolutional Network. Energy, 2022;25(4): 124313.

[86] United States Pharmacopeia. FDA’s Draft Guidance on Topical Ophthalmic Drug Products and USP Standards. Quality Matters, 2024

[87] European Medicines Agency. Guideline on Quality and Equivalence of Locally Applied and Locally Acting Cutaneous Products2018;70(8):28

[88] U.S. Food and Drug Administration. Quality Considerations for Topical Ophthalmic Drug Products. Draft Guidance, Dec. 2023.

[89] Almeida, Ana J., Eliana B. Souto, and Ana M. Silva. Nanoparticles for Delivery of Therapeutic Peptides and Proteins. 2019;11(9):460.

[90] Kumar, Vinay, Abul K. Abbas, and Jon C. Aster. Robbins Basic Pathology. 10th ed., Elsevier, 2019. PubMed Central

[91] La Rosa, Mario, Allergic Conjunctivitis: A Comprehensive Review of the Literature. Italian Journal of Pediatrics, 2013;39(18)

[92] Parekh, Bela, and Jai G. Parekh. Ocular Surface Disease Treatments in the Pipeline. Ophthalmology Management, May 2025;29(5):14–15.

[93] Kim, Hyeong Min, and Se Joon Woo. Ocular Drug Delivery to the Retina: Current Innovations and Future Perspectives. Pharmaceutics, 2021;13(1):108.

[94] Raj, Vishal Kumar, Rupa Mazumder, and Monika Madhra. Ocular Drug Delivery System: Challenges and Approaches. International Journal of Applied Pharmaceutics2020;12(5):49–57.

[95] Abdelrahman, A. M., and G. S. El-Feky. Light-responsive polymeric nanoparticles for retinal drug delivery: Design cues, challenges and future perspectives.Heliyon

[96] Kumar, Anil, Rajesh Singh, and Priya Sharma. Impact of Artificial Intelligence on Sustainable Agriculture: Opportunities and Challenges. Heliyon, 2024;10(12):26-47.

[97] Gorantla, Srividya, Nanocarriers for ocular drug delivery: Current status and translational opportunity. RSC Advances, 2020;10(45):27835–27855.

[98] Kumar, Vinay, Abul K. Abbas, and Jon C. Aster. Robbins and Cotran Pathological Basis of Disease. Indian Journal of Pathology and Microbiology, 2014;57(1):1–3.

[99] Occhiutto, Marcelo L. Breakdown of the Blood-Ocular Barrier as a Strategy for the Systemic Use of Nano systems. Pharmaceutics, 2012;4(2):252–275.

[100] Kumar, Amit, Anjali Singh, and Rajesh Singh. A Novel Hybrid Approach for COVID-19 Detection Using Chest X-Ray Images. Scientific Reports, , 2021;11(1):98-99

[101] Zhang, Y., Li, X., Wang, J., and Chen, H. Nanoparticle-Based Drug Delivery Systems for Cancer Therapy: Advances and Challenges. International Journal of Nanomedicine 2024;19(1): 532074.

[102] Ong, Frank S Personalized Medicine in Ophthalmology: From Pharmacogenetic Biomarkers to Therapeutic and Dosage Optimization. Journal of Personalized Medicine, 2013;3(1):40–69.

[103] Bachu, Rinda Devi, Ocular Drug Delivery Barriers—Role of Nanocarriers in the Treatment of Anterior Segment Ocular Diseases. Pharmaceutics, 2018;10(1):28.

[104] Zhang, Y Title of the Article. Nature Communications, , 2023;14(24):75.

[105] Pushkaran, Anju Choorakottayil, and Alya A. Arabi. From Understanding Diseases to Drug Design: Can Artificial Intelligence Bridge the Gap Artificial Intelligence Review, 2024;57:86.